Charles A. Deignan
Overview
Charles A. Deignan received an average of $867K in total compensation, including $328K in salary, at Clearside Biomedical from 2015 to 2023.
2023Clearside BiomedicalChief Financial Officer
2022Clearside BiomedicalChief Financial Officer
2021Clearside BiomedicalChief Financial Officer
2020Clearside BiomedicalChief Financial Officer
2018Clearside BiomedicalChief Financial Officer
2017Clearside BiomedicalChief Financial Officer
2016Clearside BiomedicalChief Financial Officer
2015Clearside BiomedicalChief Financial Officer
Source: SEC filings on April 26, 2024, April 28, 2023, April 29, 2022, April 26, 2019, April 27, 2018, and April 28, 2017.
Related executives
We found five more executives who work or worked at Clearside Biomedical.
News
Clearside Biomedical CEO George Lasezkay's 2023 pay stays at $1.5M
April 26, 2024
Clearside Biomedical CEO George Lasezkay's 2022 pay falls 35% to $1.5M
April 28, 2023
Clearside Biomedical President and Chief Executive Office George Lasezkay's 2021 pay jumps 71% to $2.3M
April 29, 2022
Clearside Biomedical Chief Commercial Officer Brion Raymond receives $954K in 2018
April 26, 2019